CRISPR Archives

News and Trends 6 Aug 2015

Here are 7 Biotech Stories you Must Read During the Holidays

The Holidays are a perfect time to enjoy the sun and relax peacefully on the beach but it’s also a great time to read inspiring stories about your favorite topic, Biotechs! For your delight, we bring you the most read biotech stories of this year. Discover or re-discover them and enjoy! January – The CRISPR’s Therapeutical revolution Six […]

August 6, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 15 Jul 2015

How Servier saved Cellectis, the French CAR-T Miracle

Cellectis, the €1bn CAR-T company, just announced it reached a significant milestone in its collaboration with Servier. Surprisingly, early 2014, Cellectis and its 300 employees were only three months away from bankruptcy, mainly because of the competing gene-editing technology CRISPR. How and why did Servier save them? Let’s find out. Cellectis was founded in 1999 in Paris and […]

July 15, 2015 - 5 minutesmins - By Philip Hemme

News and Trends 9 Jul 2015

Meet Eligo, the Startup which Raised €2M to Redefine Antibiotics using CRISPR

Antibiotic resistance is a public health problem worldwide. According to WHO, by 2050, over 10 million people will die every year. Microbiomics is a fast evolving field which could play an important role in fighting these resistant bacteria. And CRISPR is literally seen as the biggest Biotech discovery of this century. So, here’s a crazy thought… what would […]

July 9, 2015 - 6 minutesmins - By Philip Hemme

News and Trends 10 Jun 2015

French collaboration to develop Oncology-targeted Therapy

PEP-Therapy and CleveXel Pharma will co-develop targeted therapy in oncology. The product is based on an innovative technology involving bi-functional peptides that penetrate cells, and specifically block pathological mechanisms without affecting physiological mechanisms. The drug candidate is a cell-penetrating peptide that targets an interaction between two intracellular proteins, Caspase-9 and PP2A. It has been validated […]

June 10, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 1 Jun 2015

CRISPR technology receives the Spanish ‘Nobel prize’

CRISPR continues to amass prizes and to consolidate itself as the biggest discovery of the century. Its discoverers received last Wednesday the Princess of Asturias Award of Technical and Scientific Research. Emmanuel Charpentier and Jennifer Doudna, who shared the prize, received €50k. The prize was established in 1980 and consists in a series of annual prizes […]

June 1, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 26 May 2015

CRISPR-armed Viruses to kill Antibiotic-Resistant Bacteria

Antibiotics abuse is creating a whole new generation of antibiotic-resistant bacteria. As the tolerance to antibiotics grows, the battle against bacteria is getting harder and becoming a public issue. However, Humans are not the only ones trying to fight bacteria. Some viruses, the phages, have been doing it for millenniums. Udi Qimron and his team […]

May 26, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 30 Apr 2015

Gene-editing Technology war continues while CRISPR Therapeutics raised €79.5M

As the CRISPR-Cas9 war still goes on, CRISPR Therapeutics closed a Series A and B financing round with €79.5M. The oversubscribed financing rounds were led by strategic investors, GlaxoSmithKline‘s SR One and Celgene Corporation, respectively and also included other actors already known by the company, such as Versant Ventures, along with new ones namely New […]

April 30, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 25 Apr 2015

Desktop Genetics launches a new Gene Editing Platform

Desktop Genetics has just launched the DeskGen Platform for gene editing. It combines elements of the Company’s earlier tools, and allows researchers to design genome editing vectors and cloning strategies optimized to their own laboratories and experimental needs. The DeskGen platform gives life scientists the power to expertly design optimized genome editing experiments in any cell […]

April 25, 2015 - 2 minutesmins - By Julie Lellouche

News and Trends 8 Apr 2015

CRISPR Therapeutics opens Boston R&D Office to Win the CRISPR War

CRISPR Therapeutics appointed Bill Lundberg to Chief Scientific Officer to lead the company’s development programs and to spearhead the creation of its R&D operations in Cambridge, Massachusetts. The biopharmaceutical company was founded in Basel, Switzerland, by Emanuelle Charpentier, one of the pioneer scientists in the CRISPR field. The company is focused on translating CRISPR-Cas9 gene-editing […]

April 8, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 6 Apr 2015

Gene editing to make French fries less unhealthy

A promising biotechnological approach or an innovative way of avoiding regulation? Large companies spend an average of €126M on the development of a genetically engineered crop (GMO), including €32M in regulatory costs. The Agriculture Department once takes two to five years to review applications, though it is trying to reduce that to 13 to 16 […]

April 6, 2015 - 4 minutesmins - By Cédric Brock

News and Trends 10 Mar 2015

Live from Bio-Europe 2015: The product development challenges in the gene therapy field

Gene Therapy is really the hot topic right now in the field of Biotech especially with technologies such as CRISPR and CAR-T therapies. The value of such companies are skyrocketing and many see the field as the next potential blockbuster therapies. Gene therapy has clearly a huge potential but also lot of challenges, let’s go through […]

March 10, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 21 Jan 2015

Review: The CRISPR’s Therapeutical revolution

Six years ago, a new sophisticated prokaryotic defense system, was identified in the structure complex CRISPR-Cas9 (CRISPR, clustered regularly interspaced short palindromic repeats; Cas, CRISPR associated nuclease). “Resistance is acquired by incorporating short stretches of invading DNA sequences in genomic CRISPR loci ” Brouns, S. J. J., et al. (2008). The CRISPR repeat sequence has […]

January 21, 2015 - 4 minutesmins - By Cédric Brock

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

CRISPR

Here are 7 Biotech Stories you Must Read During the Holidays

How Servier saved Cellectis, the French CAR-T Miracle

Meet Eligo, the Startup which Raised €2M to Redefine Antibiotics using CRISPR

French collaboration to develop Oncology-targeted Therapy

CRISPR technology receives the Spanish ‘Nobel prize’

CRISPR-armed Viruses to kill Antibiotic-Resistant Bacteria

Gene-editing Technology war continues while CRISPR Therapeutics raised €79.5M

Desktop Genetics launches a new Gene Editing Platform

CRISPR Therapeutics opens Boston R&D Office to Win the CRISPR War

Gene editing to make French fries less unhealthy

Live from Bio-Europe 2015: The product development challenges in the gene therapy field

Review: The CRISPR’s Therapeutical revolution

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!